Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment
about
Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.Post-Mortem evaluation of amyloid-dopamine terminal positron emission tomography dementia classificationsMild cognitive impairment: clinical and imaging profile in a memory clinic setting in India.
P2860
Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Comparing fludeoxyglucose F18- ...... and mild cognitive impairment
@ast
Comparing fludeoxyglucose F18- ...... and mild cognitive impairment
@en
type
label
Comparing fludeoxyglucose F18- ...... and mild cognitive impairment
@ast
Comparing fludeoxyglucose F18- ...... and mild cognitive impairment
@en
prefLabel
Comparing fludeoxyglucose F18- ...... and mild cognitive impairment
@ast
Comparing fludeoxyglucose F18- ...... and mild cognitive impairment
@en
P2093
P2860
P1433
P1476
Comparing fludeoxyglucose F18- ...... and mild cognitive impairment
@en
P2093
Bruno Giordani
James F Burke
Kirk A Frey
Michael R Kilbourn
Robert A Koeppe
Roger L Albin
Sid Gilman
P2860
P304
P356
10.1001/ARCHNEUROL.2010.34
P577
2010-04-01T00:00:00Z